# CLARINEX
> **NDA021363** · New Drug Application · Sponsor: SCHERING · Approved 2002-02-08
## Drug
- **FDA Application Number:** NDA021363
- **Application type:** New Drug Application
- **Brand name:** CLARINEX
- **Generic name:** Desloratadine
- **Active ingredients:** DESLORATADINE
- **Dosage form:** Tablet
- **Route:** Oral
- **Marketing status:** Prescription
- **Sponsor:** SCHERING
- **First approval:** 2002-02-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021363)
---
*AI Analytics · CC0 1.0*